News
Company's first development candidate in autoimmune and inflammatory disease (AIID) demonstrates potent blockade of IL-4, IL-13, and IL-33 signaling pathways critical in respiratory inflammationNovel ...
Microsoft Build 2025 in Seattle featured news around MCP support, building artificial intelligence agents and bringing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback